Skip to main content

Closed

TLSA: Tiziana Life Sciences Ltd Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-41.2%

Financially safe

Stretched

Debt / equity0.01×

Interest coverage-112.8×

Current ratio8.79×

Tiziana Life Sciences Ltd

TLSANASDAQ Global Market·USD·Closed

Tiziana Life Sciences Ltd

TLSANASDAQ·USD·Closed

$1.03

+6.19%

$1.03

+$0.06 (6.19%)

52W Range

9thpctl

Volume

1.50×avg

Mkt Cap

65.54MUSD

P/E

-4.2TTM

Div Yield

–ann

52W Range

9thpctl

Volume

1.50×avg

Market Cap

65.54MUSD

P/E Ratio

-4.2TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings